Tag

Immunicum

Sven Rohmann

He is the new Chief Executive Officer of Immunicum

August 28, 2020

Immunicum has announced that Sven …

Alex Karlsson Parra

Immunicum updates survival data from Phase II trial

August 18, 2020

Immunicum has announced an update …

Carlos de Sousa

Carlos de Sousa resigns as CEO of Immunicum

December 13, 2019

The Board of Directors of …

Immunicum announces positive preclinical data on Ilixadencel in combination with CTLA-4

October 23, 2019

The company has announced results …

Carlos de Sousa

Immunicum announces data analysis from Phase II trial

September 25, 2019

The company has announced the …

Carlos de Sousa

Exciting results from Immunicum

August 29, 2019

The company has announced positive …

Carlos de Sousa

Immunicum announces positive trial results

June 12, 2019

The company has completed and …

Cancer cells

First patient treated in Immunicum trial

February 11, 2019

The first patient has been …

carlos-de-sousa-immunicum

Immunicum’s clinical trial application approved

February 16, 2017

Immunicum announces that the Agence …

Jamal El-Mosleh

Immunicum raises approx SEK 128 million in oversubscribed rights issue

June 23, 2016

Immunicum’s rights issue of approximately …

immunicum

New results from Immunicum

March 11, 2016

Immunicum announces an update on …

Kidney Cancer Drug Trial Starts

Ellen R. Delisio

May 6, 2015

Immunicum has started its phase …

Athena Prize Goes to Cancer Vaccine

Ellen R. Delisio

February 5, 2015

Sweden’s Athena Prize, healthcare’s largest …

Immunicum presents data from phase I/II study

May 22, 2014

Immunicum has announced continued compelling survival …

Immunicum announces positive data

December 6, 2013

Immunicum announces positive survival data …